ARS Pharmaceuticals, Inc (SPRY) — Free Cash Flow Generation Index
ARS Pharmaceuticals, Inc (SPRY) has a Free Cash Flow Generation Index of 0.99x as of December 2024. Free cash flow of $41.70 Million represents 1% of operating cash flow ($42.00 Million). Read SPRY total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ARS Pharmaceuticals, Inc Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for ARS Pharmaceuticals, Inc across 2 annual periods. Explore ARS Pharmaceuticals, Inc (SPRY) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for ARS Pharmaceuticals, Inc (2020–2024)
Year-by-year Free Cash Flow Generation Index for ARS Pharmaceuticals, Inc. For the full company profile including market capitalisation, see ARS Pharmaceuticals, Inc stock valuation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.96x | $12.98 Million | $13.55 Million | $563.00K | ▲ +6.6% |
| 2020 | 0.90x | $8.15 Million | $9.07 Million | $917.00K | — |